KYMR
Kymera Therapeutics Inc
Price:  
114.67 
USD
Volume:  
1,134,757.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KYMR Stock Forecast & Price Target

KYMR Stock Price Forecast

The average stock forecast for Kymera Therapeutics Inc (KYMR) in the next 12 months is 120.47 USD. This price target corresponds to an upside of 11.42%. The range of stock forecasts for KYMR is 91.91 - 147.00 USD. Based on the ratings of 30 analysts, the consensus recommendation for KYMR is BUY.
Target Low Average Median High
Price (USD) 91.91 120.47 121.38 147.00
Upside -14.99% 11.42% 12.26% 35.96%

Recommendation Trends

The latest consensus rating for KYMR is "BUY". This is the average recommendation of 30 analysts: 0 strong sell, 0 sell, 2 hold, 17 buy, 11 strong buy. In the previous period, 29 analysts also majorly recommmended "BUY" for KYMR.

KYMR Financial Stock Forecast

Revenue This Year
91.79M
134.10%
from 39.21M
Revenue Next Year
41.53M
-54.75%
from 91.79M
EPS This Year
-3.49
-7.82%
from -3.78
EPS Next Year
-4.28
22.78%
from -3.49